A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
Shanghai Henlius Biotech
Pfizer
Biocon Limited
Herlev Hospital
Alvotech Swiss AG
Duke University
M.D. Anderson Cancer Center
McMaster University
AccSalus Biosciences, Inc.
Petrov, Andrey
Hangzhou DAC Biotechnology Co., Ltd.
Vastra Gotaland Region
Biotroy Therapeutics
Ankyra Therapeutics, Inc
Boston Immune Technologies and Therapeutics
Peking University Cancer Hospital & Institute
Vastra Gotaland Region